Cannabis Investing News
See our exclusive index of companies on the move:
Explore Stocks- Top Stocks
- Top Australian Gold Stocks
- Top ASX Copper Stocks
- Top ASX Nickel Stocks
- Top ASX Rare Earth Stocks
- Top Battery Metals Stocks on the ASX
- Top Australian Lithium Stocks
- Top Graphite Miners on the ASX
- 10 ASX Cannabis Stocks
- Top ASX Tech Stocks
- Top AI Stocks on the ASX
- On Site
- About Australian Cannabis Investing
- About Australian Resource Investing
- About Australian Tech Investing
- About Australia Investing
- Of Interest
- ASEAN-Australia-New Zealand Trade Agreement
- Association of Southeast Asian Nations (ASEAN)
- Australian FAQ on ASEAN
- Australia Government on Foreign Investments
Asterion Cannabis Officially Listed on the Australian Department of Health and Office of Drug Control
Asterion Cannabis is listed as a medicinal cannabis manufacturer and supplier on the Australian government’s Department of Health and Office of Drug Control.
Asterion Cannabis is listed as a medicinal cannabis manufacturer and supplier on the Australian government’s Department of Health and Office of Drug Control. The list dated January 22, 2020, indicates that Asterion Cannabis is, “licensed under the Narcotic Drugs Act 1967 (ND Act) to manufacture medicinal cannabis products.” Asterion Cannabis is a vertically-integrated Canadian cannabis company that is developing a state-of-the-art 4.3-million-square-foot greenhouse facility in Southeast Queensland, Australia. The company’s focus is to be a leader in precision agriculture and to produce high-quality, low-cost and genetically-uniformed cannabis strains and products.
Click here to connect with Asterion Cannabis Inc. for an Investor Presentation.
Top News
FEATURED STOCKS
Global News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.